Fluoroquinolones: Difference between revisions
No edit summary |
Ostermayer (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
* [[PID]] | * [[PID]] | ||
* [[Traveler's Diarrhea]] | * [[Traveler's Diarrhea]] | ||
==Adverse Effects== | |||
*Black box warning from US FDA | |||
#Tendon Rupture & Tendinitis <ref>Gültuna S. et al. Ciprofloxacin induced tendinitis. J Clin Rheumatol. 2009;15 (4): 201-2</ref> | |||
#Peripheral Neuropathy<ref>Food and Drug Administration: Drug safety announcement about fluoroquinolones and possible peripheral neuropathy [http://www.fda.gov/downloads/Drugs/DrugSafety/UCM365078.pdf PDF]</ref> | |||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
Line 12: | Line 19: | ||
==Source== | ==Source== | ||
Goodman & Gilman's Pharmacology | *Goodman & Gilman's Pharmacology | ||
*[http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm126085.htm FDA info for Health Professionals] | |||
<references/> | |||
[[Category:ID]] | [[Category:ID]] | ||
[[Category:Drugs]] | [[Category:Drugs]] |
Revision as of 22:35, 17 May 2014
Indications
- UTI (2nd line)
- Prostatitis
- Chlamydia
- PID
- Traveler's Diarrhea
Adverse Effects
- Black box warning from US FDA
|
See Also
Source
- Goodman & Gilman's Pharmacology
- FDA info for Health Professionals